期刊文献+

IL-6/IL-6受体与相关临床疾病的研究进展 被引量:13

Advances on the studies of interleukin-6/interleukin-6 receptor and associated clinical diseases
原文传递
导出
摘要 IL-6作为一个多效的细胞因子,在损伤、修复、免疫应答、炎症反应以及造血中担任重要角色,且影响着许多疾病的发生发展,如自身免疫病、肿瘤、神经系统疾病等。因此,调节IL-6有可能成为治疗某些疾病的新战略。 Interleukin-6 (IL-6) is a pleiotropic cytokine that plays a major role in the injury or rehabilitation, immune response, inflammation and hematopoiesis. In addition, it impacts on numerous disease states, including autoimmune diseases, tumour and diseases in nervous system et al. Consequently, modulating IL-6 may he an innovative therapeutic strategy in some diseases.
出处 《武警后勤学院学报(医学版)》 CAS 2012年第10期821-824,F0004,共5页 Journal of Logistics University of PAP(Medical Sciences)
基金 国家自然科学基金项目(81041071)
关键词 IL-6 IL-6受体 疾病 Interleukin-6 IL-6 receptor Disease
  • 相关文献

参考文献23

  • 1David S Hong,Laura S Angelo,Razelle Kurzrock. Interleukin-6 and its receptor in cancer[J].Cancer,2007,(09):1911-1928.
  • 2K Fizazi,JS De Bono,A Flechon. Randomised phase Ⅱ study of siltuximab(CNTO 328),an anti-IL-6 monoclonal antibody in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer[J].European Journal of Cancer,2012,(01):85-93.
  • 3Flower L,Gray R,Pinkney J. Stimulation of interleukin-6 release by interleukin-1beta from isolated human adipocytes[J].Cytokine,2003.32-37.
  • 4Kayacan O,Karnak D,Beder S. Impact of TNF-alpha and IL-6 levels on development of cachexia in newly diagnosed NSCLC patients[J].American Journal of Clinical Oncology,2006.328-335.
  • 5Scheller J,Ohnesorge N,Rose-John S. Interleukin-6 transsignaling in chronic inflammation and cancer[J].Scandinavian Journal of Immunology,2006.321-329.
  • 6苗平,陆梅生,张冬青.IL-6/IL-6受体与类风湿关节炎关联性研究新进展[J].免疫学杂志,2011,27(4):355-360. 被引量:69
  • 7Montero-Julian FA. The soluble IL-6 receptors:serum levels and biological function[J].Cellular and Molecular Biology,2001.583-597.
  • 8Gustot T,Lemmers A,Louis E. Profile of soluble cytokine receptors in Crohn's disease[J].Gut,2005.488-495.
  • 9Atreya R,Neurath MF. Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer[J].Clinical Reviews in Allergy & Immunology,2005.187-196.
  • 10Maini RN,Taylor PC,Szechinski J. Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist,tocilizumab,in European patients with rheumatoid arthritis who had an incomplete response to methotrexate[J].Arthritis and Rheumatism,2006.2817-2829.

二级参考文献57

  • 1王越,杨洁,高燕,牛文彦,姚智.卵巢癌细胞IL-6、IL-8及其受体表达的研究[J].免疫学杂志,2006,22(5):475-479. 被引量:16
  • 2Pflegerl P, Vesely P, Hantusch B, et al. Epidermal loss of JunB leads to a SLE phenolype due to hyper IL-6 signaling [J]. Proceedings of the National Academy of Sciences of the United States of America, 2009, 106(48): 20423-20428.
  • 3Knupfer H, Preiss sIL-6R: more than an agonist? [J]. Immunol Cell biol, 2008, 86(1): 87-91.
  • 4Heinrich PC, Behrmann I, Muller-Newen G, et al. Interleukin-6-type cytokine signalling through the gpl30/Jak/STAT pathway [J]. Biochem J, 1998, 334 ( Pt 2): 297-314.
  • 5Novotnydiermayr V, Lin B, Gu L, et al. Modulation of the interleukin-6 receptor subunit glycoprotein 130 complex and its signaling by LMO4 interaction [J]. The Journal of biological chemistry, 2005, 280(13): 12747-12757.
  • 6Frey N, Grange S, Woodworth T. Population Pharmacokinetic Analysis of Tocilizumab in Patients With Rheumatoid Arthritis [J]. J Clin Pharmacol, 2010, 50(7):754-766.
  • 7Jazayeri JA, Carroll GJ, Vernallis AB. Interleukin-6 subfamily cytokines and rheumatoid arthritis: role of antagonists [J]. Int Immunopharmacol, 10(1): 1-8.
  • 8Dayer JM, Choy E. Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor [J]. Rheumatology (Oxford, England), 2010, 49(1): 15-24.
  • 9Dienz O, Eaton SM, Bond JP, et al. The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells [J]. J Exp Med, 2009, 206(1): 69-78.
  • 10Youinou P, Jamin C. The weight of interleukin-6 in B cell-related autoimmune disorders [J]. J Autoimmun, 2009, 32(3/4): 206-210.

共引文献71

同被引文献141

引证文献13

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部